EFX: Stock thesis & analysis
As of 09-01-2026
📁 From our research archive: this thesis was generated on 09-01-2026 and may not reflect our current view. See the latest research →
Equifax is a durable data-franchise with recurring-revenue economics, but at 33.8x P/E and 23.5x P/FCF against ROE of only 14% and D/E above 120%, valuation is not compelling relative to quality metrics — composite fundamentals score is weak at 37.9/100. Smart-money confirmation is thin (2 tracked funds, one new initiation, no cluster), and the stock sits in Industrials, the second-weakest sector in the current regime (rank 10 of 11), creating a real cyclical headwind rather than a stock-specific opportunity. With leverage elevated and macro tilt unsupportive, this is not an attractive entry at the current price.
Catalysts to watch
- Potential margin recovery if mortgage/hiring-related data volumes reaccelerate
- Analyst upgrade momentum (Rothschild & Co, 2026-08-21) could continue if Q3 earnings beat
- Further deleveraging or debt refinancing announcement could ease balance-sheet concerns
Key risks
- Elevated leverage (D/E ~121%) limits balance-sheet flexibility in a slowing macro
- Valuation (33.8x P/E) prices in consistent double-digit growth that recent fundamentals do not yet support
- Industrials sector is currently the second-weakest performing sector in the active regime
- Thin institutional confirmation — only 2 tracked funds, one newly initiated, no multi-quarter persistence
- Credit conditions show a late-cycle warning signal that argues for caution on richly-valued names generally
What would change the view
- Stock breaks below $165.00
- Op margin falls below 15% for 2 consecutive quarters
- D/E rises above 140% without a deleveraging plan disclosed